Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Daniel H. S. Silverman"'
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
Accumulating evidence suggests amyloid and tau-related neurodegeneration may play a role in development of late-onset epilepsy of unknown etiology (LOEU). In this article, we review recent evidence that epilepsy may be an initial manifestation of an
Externí odkaz:
https://doaj.org/article/3b51eb8e8a564c2cbd9039140f8a487b
Autor:
Eileen G. Fowler, William L. Oppenheim, Marcia B. Greenberg, Loretta A. Staudt, Shantanu H. Joshi, Daniel H. S. Silverman
Publikováno v:
Frontiers in Human Neuroscience, Vol 14 (2020)
Reduced selective voluntary motor control (SVMC) is a primary impairment due to corticospinal tract (CST) injury in spastic cerebral palsy (CP). There are few studies of brain metabolism in CP and none have examined brain metabolism during a motor ta
Externí odkaz:
https://doaj.org/article/2352775c2bf34bb181fb8793abfa432f
Publikováno v:
Journal of Nuclear Medicine. 63:180-182
Autor:
Natalie L Rasgon, Cheri L Geist, Heather A Kenna, Tonita E Wroolie, Katherine E Williams, Daniel H S Silverman
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e89095 (2014)
The objective of this study was to examine the effects of estrogen-based hormone therapy (HT) on regional cerebral metabolism in postmenopausal women (mean age = 58, SD = 5) at risk for development of dementia. The prospective clinical trial design i
Externí odkaz:
https://doaj.org/article/118fbae5adb4488b9de0cfcfee9db41e
Autor:
Thomas E. Witzig, Richard B. Sparks, Dominick Lamonica, Daniel H. S. Silverman, Christine A. White, Gregory A. Wiseman, Stewart M. Spies, Bryan Leigh, Ellen Kornmehl, William D. Erwin
Publikováno v:
Cancer. 94:1349-1357
BACKGROUND Zevalin consists of a murine anti-CD20 monoclonal antibody (ibritumomab) conjugated to the linker-chelator tiuxetan, which securely chelates indium-111 (111In) for imaging and dosimetry and yttrium-90 (90Y) for radioimmunotherapy (RIT). Pr
Autor:
Tina W, Lin, Michelle A Kung, de Aburto, Magnus, Dahlbom, Lynn L, Huang, Michael M, Marvi, Michael, Tang, Johannes, Czernin, Michael E, Phelps, Daniel H S, Silverman
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 48(5)
Conventional visual analysis of brain (18)F-FDG PET scans is useful for predicting postsurgical improvement for temporal lobe epilepsy (TLE) patients, but prognostic value for identifying patients who will achieve seizure-free status is considerably
Autor:
Wei-Ann, Hsueh, Amanda L, Kesner, Anne, Gangloff, Mark D, Pegram, Malgorzata, Beryt, Johannes, Czernin, Michael E, Phelps, Daniel H S, Silverman
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 47(12)
Paclitaxel is used as a chemotherapy drug for the treatment of various malignancies, including breast, ovarian, and lung cancers. To evaluate the potential of a noninvasive prognostic tool for specifically predicting the resistance of tumors to pacli
Autor:
Adam L, Kesner, Magnus, Dahlbom, Sung-Cheng, Huang, Wei-Ann, Hsueh, Betty S, Pio, Johannes, Czernin, Michael, Kreissl, Hsiao-Ming, Wu, Daniel H S, Silverman
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 47(7)
The objective of the work reported here was to develop and test automated methods to calculate biodistribution of PET tracers using small-animal PET images.After developing software that uses visually distinguishable organs and other landmarks on a s
Autor:
Wei, Chen, Daniel H S, Silverman, Sibylle, Delaloye, Johannes, Czernin, Nirav, Kamdar, Whitney, Pope, Nagichettiar, Satyamurthy, Christiaan, Schiepers, Timothy, Cloughesy
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 47(6)
We evaluated the amino acid and glucose metabolism of brain tumors by using PET with 3,4-dihydroxy-6-(18)F-fluoro-l-phenylalanine ((18)F-FDOPA) and (18)F-FDG.Eighty-one patients undergoing evaluation for brain tumors were studied. Initially, 30 patie
Autor:
Anne, Gangloff, Wei-Ann, Hsueh, Amanda L, Kesner, Dale O, Kiesewetter, Betty S, Pio, Mark D, Pegram, Malgorzata, Beryt, Allison, Townsend, Johannes, Czernin, Michael E, Phelps, Daniel H S, Silverman
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 46(11)
Paclitaxel (PAC) is widely used as a chemotherapy drug in the treatment of various malignancies, including breast, ovarian, and lung cancers. We examined the biodistribution of (18)F-fluoropaclitaxel ((18)F-FPAC) in mice with and without human breast